Abstract
Background
In the past decade, the range of contraceptives available has increased dramatically. There are limited data on the factors that determine women’s choices on contraceptive alternatives or what factors providers consider most important when recommending contraceptive products to women.
Objectives
Our objectives were to compare women’s (consumers’) preferences and GPs’ (providers’) views in relation to existing and new contraceptive methods, and particularly to examine what factors increase the acceptability of different contraceptive products.
Methods
A best-worst attribute stated-choice experiment was completed online. Participants (Australian women of reproductive age and Australian GPs) completed questions on 16 contraceptive profiles. 200 women of reproductive age were recruited through a commercial panel. GPs from all states of Australia were randomly sampled and approached by phone; 162 GPs agreed to participate. Participants chose the best and worst attribute levels of hypothetical but realistic prescribed contraceptive products. Best and worst choices were modelled using multinomial logit and product features were ranked from best to worst according to the size of model coefficients.
Results
The most attractive feature of the contraceptive products for both GPs and women consumers were an administration frequency of longer than 1 year and light or no bleeding. Women indicated that the hormonal vaginal ring was the least attractive mode of administration.
Conclusions
Women and GPs agree that longer-acting methods with less bleeding are important features in preferred methods of contraception; however, women are also attracted to products involving less invasive modes of administration. While the vaginal ring may fill the niche in Australia for a relatively non-invasive, moderately long-acting and effective contraceptive, the results of this study indicate that GPs will need to promote the benefits of the vaginal ring to overcome negative perceptions about this method among women who may benefit from using it.
Similar content being viewed by others
References
Yusuf F, Siedlecky S. Patterns of contraceptive use in Australia: analysis of the 2001 national health survey. J Biosoc Sci 2007; 39(5): 735–44
Gray E, McDonald P. Using a reproductive life course approach to understand contraceptive method use in Australia. J Biosoc Sci 2010; 42(1): 43–57
Novák A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, Nuvaring: an international study of user acceptability. Contraception 2002; 67: 187–94
Fiebig DG, Knox S, Viney R, et al. Preferences for new and existing contraceptive products. Health Econ 2011; 20: 35–52
Flynn TN, Louviere JJ, Peters TJ, et al. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ 2007; 26(1): 171–89
Louviere JJ, Islam T. A comparison of importance weights and willingness-to-pay measures derived from choice-based conjoint, constant sum scales and best-worst scaling. J Bus Res 2008; 61: 903–11
Marley AAJ, Louviere JJ. Some probabilistic models of best, worst, and best-worst choices. J Math Psychol 2005; 49: 464–80
Marley AAJ, Flynn TN, Louviere JJ. Probabilistic models of set-dependent and attribute level best-worst choices. J Math Psychol 2008; 52: 281–96
Hall J, Fiebig DG, King MT, et al. What influences participation in genetic carrier testing? Results from a discrete choice experiment. J Health Econ 2006; 25(3): 520–37
Lancsar E, Louviere J, Flynn T. Several methods to investigate relative attribute impact in stated preference experiments. Soc Sci Med 2007; 64(8): 1738–53
Fiebig DG, Haas M, Hossain I, et al. Decisions about Pap tests: what influences women and providers? Soc Sci Med 2009; 68(10): 1766–74
Coast J, Salisbury C, de Berker D, et al. Preferences for aspects of a dermatology consultation. Br J Dermatol 2006; 155(2): 387–92
Coast J, Flynn TN, Natarajan L, et al. Valuing the ICECAP capability index for older people. Soc Sci Med 2008; 67(5): 874–82
Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark 1992; 11(2): 12–25
Street DJ, Burgess L. The construction of optimal stated choice experiments: theory and methods. Hoboken (NJ): Wiley, 2007
Survey Sampling International [online]. Available from URL: http://www.surveysampling.com/en/forms/global-panel-book [Accessed 2009 Feb 15]
Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2007–2008. Canberra: Australian Institute of Health and Welfare, 2008
Australian Bureau of Statistics. Australian historical population statistics. Canberra (ACT): ABS, 2006
Gilliam M, Holmquist S, Berlin A. Factors associated with willingness to use the contraceptive vaginal ring. Contraception 2007; 76: 30–4
Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol 2008; 111 (2 Pt 1): 267–77
de Bekker-Grob EW, Essink-Bot ML, Meerding WJ, et al. Preferences of GPs and patients for preventive osteoporosis drug treatment: a discrete-choice experiment. Pharmacoeconomics 2009; 27(3): 211–9
Ratcliffe J, Couzner L, Flynn T, et al. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Appl Health Econ Health Policy 2011; 9(1): 15–27
Potoglou D, Burge P, Flynn T, et al. Best-worst scaling vs. discrete choice experiments: an empirical comparison using social care data. Soc Sci Med 2011; 72(10): 1717–27
Acknowledgements
This work was undertaken at the Centre for Health Economics Research and Evaluation, University of Technology Sydney.
This project was funded by the Australian Research Council (ARC) as an ARC linkage grant, a partnership grant between the University of Technology Sydney (Centre for Health Economics Research and Evaluation) and the following industry partners: Family Planning NSW, Organon Australia Pty Ltd, Schering Pty Ltd, and Janssen-Cilag Pty Ltd.
Authors E. Weisberg and D. Bateson are employed by Family Planning NSW and were involved in the study design and interpretation of the results. Family Planning NSW has received grants from Bayer HealthCare and MSD for training programmes and also provides independent expert advice to MSD, Pfizer and Bayer HealthCare on contraception. Family Planning NSW did not provide any financial support for the study. The other funding organisations were not involved in the design or conduct of the study nor the analysis or interpretation of the results. The authors S.A. Knox, R.C. Viney, M.R. Haas, D.J. Street and D.G. Fiebig have no conflicts of interest. The authors would like to thank Clarissa House-Watson for her assistance in recruiting the GPs into the study.
Author contributions: S.A. Knox researched the chosen method, undertook construction of the design and simulation testing, supervised online set-up of the experiment and recruitment, undertook analysis, contributed to the literature review and lead the writing of the manuscript.
R.C. Viney contributed to the conception of the study and the planning of focus groups, and was involved in the choice of task, selecting attributes and levels, the recruitment of GPs, the interpretation of results, and writing and editing the manuscript
M.R. Haas contributed to the conception of the study, the planning of focus groups, the choice of task, selecting attributes and levels, the interpretation of results, and writing and editing the manuscript.
D.G. Fiebig contributed to the choice of task, gave advice on analysis and interpretation of the results, and contributed to writing and editing the manuscript.
D.J. Street was involved in the choice of task, undertook construction of design and supervised simulation testing, and contributed to writing and editing the manuscript.
E. Weisberg contributed to the conception of the study, the planning and running of focus groups, the selection of attributes and levels, recruitment of GPs and writing the manuscript.
D. Bateson contributed to the conception of the study, the selection of attributes and levels, the recruitment of GPs and writing the manuscript.
S.A. Knox acts as guarantor for the overall content of this paper.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Knox, S.A., Viney, R.C., Street, D.J. et al. What’s Good and Bad About Contraceptive Products?. PharmacoEconomics 30, 1187–1202 (2012). https://doi.org/10.2165/11598040-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11598040-000000000-00000